Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
暂无分享，去创建一个
O. Christophe | G. Ronzitti | Laetitia van Wittenberghe | C. Leborgne | F. Fallarino | T. Kishimoto | A. Vignaud | F. Mingozzi | P. Ilyinskii | S. Marmier | S. Charles | F. Collaud | C. Roy | Marcelo Simon Sola | R. Hardet | F. Boisgérault | Giorgia Manni | Helena Costa Verdera | Amine Meliani | Alicia M Michaud | L. van Wittenberghe | Alicia M. Michaud